Skip to main content
Clinical Trials/NCT04924673
NCT04924673CompletedNot Applicable

Study of the Changes in Glycemic Control and Psychological Distress in Diabetic Patients After the Confinement Period Related to the COVID-19 Epidemic

Rennes University Hospital11 sites in 1 country202 target enrollmentStarted: June 17, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
202
Locations
11
Primary Endpoint
HbA1c

Study Overview

Brief Summary

Prospective, non-interventional, multicentric study

Detailed Description

The rapid spread of the COVID-19 pandemic and the isolation at home implemented in France, creates unprecedented challenges for diabetic patients.

Patients with diabetes have been considered to be at higher risk of infection by the virus, with a greater risk of mortality; this has been a great source of anxiety for them.

It is well known that stress has an impact on plasma glucose levels. The French situation where a general confinement has been decreed over the whole territory (which is not the case for all countries) and for a period of two months, makes it possible to study the impact of this unique situation on stress, sedentary lifestyle, changes in diet and decrease in physical activity. There are no similar experiences described in the literature.

The investigators hypothesize there will be an increase of HbA1c in the coming months.

The main objective is to assess changes in glycemic control in diabetic patients after the confinement period.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patient (≥ 18 years old)
  • Diabetic patient (type 1 or type 2) regardless of their diabetes treatment who experienced complete confinement in their own home, in France.
  • Patients who had a measured HbA1 or an estimated HbA1c with a glucose sensor Freestyle libre with a known result, between November 1, 2019 and February 29,
  • Patients agreeing to have their HbA1c measured between May 15 and July 31,
  • Having been informed of the study and not objecting to participating in it

Exclusion Criteria

  • Adults over the age of legal protection (safeguard of justice, curatorship, guardianship), persons deprived of their liberty.

Outcomes

Primary Outcomes

HbA1c

Time Frame: Baseline

The change in HbA1c over the first confinement period as compared to the value in early 2020.

Secondary Outcomes

  • Stress(Baseline)

Investigators

Sponsor
Rennes University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (11)

Loading locations...

Similar Trials

Impact of the COVID-19 Epidemic on... | Clinical Trial